Etsuko Hashimoto

7.6k citations
118 papers · 6.5k · 2 hit papers · h-index 40

Impact in

  • Hepatology top 0.5%
    • Hepatocellular Carcinoma Treatment and Prognosis
    • Liver physiology and pathology
    • Liver Disease and Transplantation
    • Liver Diseases and Immunity
  • Epidemiology top 0.5%
    • Liver Disease Diagnosis and Treatment
    • Hepatitis B Virus Studies

Papers in

    • Hepatocellular Carcinoma Treatment and Prognosis 24
    • Liver Disease and Transplantation 13
    • Liver Diseases and Immunity 8
    • Liver physiology and pathology 3
    • Liver Disease Diagnosis and Treatment 64
    • Hepatitis B Virus Studies 8

Etsuko Hashimoto

114 papers receiving 6.2k citations

Etsuko Hashimoto's Hit Papers

Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials 2020 · 414 citations
4140+3+6Years since publication100200300400

Peers

Etsuko Hashimoto
Comparison fields: 5 of 99
  • Hepatology 1.6k
  • Epidemiology 4.3k
  • Clinical Biochemistry 63
  • Pharmacology 125
  • Endocrinology, Diabetes and Metabolism 151
Replace Elmar Stephan Aigner with:
Elmar Stephan Aigner Austria
Hirofumi Uto Japan
Masataka Seike Japan
Michelle Lai United States
Jose Antonio Solis-Herruzo Spain
Jill C. Keach United States
Christine G. Janney United States
Umberto Vespasiani Gentilucci Italy
Jan‐Peter Sowa Germany
Lars P. Bechmann Germany
Etsuko Hashimoto relative to Elmar Stephan Aigner Austria Elmar Stephan Aigner's profile →
Citations per field
00.5×2×2.7×
Elmar Stephan Aigner · 1×
Citations per year

Countries citing papers authored by Etsuko Hashimoto

Since Specialization
Citations

This map shows the geographic impact of Etsuko Hashimoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Etsuko Hashimoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Etsuko Hashimoto more than expected).

Fields of papers citing papers by Etsuko Hashimoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Etsuko Hashimoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Etsuko Hashimoto. The network helps show where Etsuko Hashimoto may publish in the future.

Co-authors

The 25 scholars most cited alongside Etsuko Hashimoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Etsuko Hashimoto Line = papers co-authored together Etsuko Hashimoto links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 118 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
Hit paper breakdown →
2020414
2
Asia–Pacific Working Party on Non‐alcoholic Fatty Liver Disease guidelines 2017—Part 1: Definition, risk factors and assessment
Hit paper breakdown →
2017407
3 2011357
4 2002303
5 2015289
6 2008279
7 2007275
8 2009253
9 2010229
10 2012228
11 2013202
12 2015185
13 2017141
14 2007130
15 2018119
16 2011107
17 2006102
18 2011102
19 2004101
20 200798

About Etsuko Hashimoto

Etsuko Hashimoto is a scholar working on Hepatology, Epidemiology, Pathology and Forensic Medicine, Pharmacology and Clinical Biochemistry, having authored 118 papers that have together received 6.5k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (64 papers), Hepatocellular Carcinoma Treatment and Prognosis (24 papers), Liver Disease and Transplantation (13 papers), Hepatitis B Virus Studies (8 papers), Liver Diseases and Immunity (8 papers), Alcohol Consumption and Health Effects (6 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Liver physiology and pathology (3 papers). The work is most often cited by research in Hepatology (1.6k citations), Epidemiology (4.3k citations), Clinical Biochemistry (63 citations), Pharmacology (125 citations) and Endocrinology, Diabetes and Metabolism (151 citations). Etsuko Hashimoto has collaborated with scholars based in Japan, Australia and China. Frequent co-authors include Katsutoshi Tokushige, Makiko Taniai, Keiko Shiratori, Satoru Yatsuji, Maki Tobari, Toshiji Saibara, Nobuyuki Torii, Jürgen Ludwig, Jose Decena Sollano and Hiroaki Okuda. Their work appears in journals such as Hepatology Research, Journal of Gastroenterology, Journal of Gastroenterology and Hepatology, Journal of Hepatology and Alcoholism Clinical and Experimental Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact